All lobbying filings

The Conafay Group, LLC

The Conafay Group, LLC filed a Q4 termination report for Acadia Pharmaceuticals Inc. on January 20, 2026, reporting $10,000 in lobbying income.

Lobbying for Acadia Pharmaceuticals Inc. · Pharmaceutical Company

As filed: THE CONAFAY GROUP, LLC for ACADIA PHARMACEUTICALS INC.

All filings by The Conafay Group, LLC · Everything Acadia Pharmaceuticals Inc. has reported

Filing · LD-2 quarterly report Q4 termination

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$10,000

What the client paid this registrant for the period.

Client based in

California

Representation ended

Dec 31, 2025

The registrant reported terminating its work for this client.

Official filing document

Lobbyists on this filing 1

DARIN L GARDNER

Previously held: Legislative Correspondent to Senator Tim Hutchinson; Research Assistant for Senate HELP Committee; Chief of Staff for Congresswoman Kay Granger

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Support for biomedical research.

Medicare/Medicaid

Medicare and Medicaid Reform.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.